Enhanced susceptibility of B lymphoma cells to measles virus by Epstein–Barr virus type III latency that upregulates CD150/signaling lymphocytic activation molecule

Measles virus (MV) is one of the candidates for the application of oncolytic virotherapy (OVT). Although an advanced clinical study has been reported on a T-cell lymphoma, the potential of MV OVT against B-cell lymphomas remains to be clarified. We found that an EBV-transformed B lymphoblastoid cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Satoshi, Kanbayashi, Daiki, Kurata, Takako, Yoshiyama, Hironori, Komano, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317819/
https://www.ncbi.nlm.nih.gov/pubmed/24238277
http://dx.doi.org/10.1111/cas.12324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317819/
https://www.ncbi.nlm.nih.gov/pubmed/24238277
http://dx.doi.org/10.1111/cas.12324

Ejemplares similares